Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Compounds with high affinity for 5-HT1A and/or D2 receptors reported by E. Merck

June 7, 1996

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

CDR-grafted type III anti-CEA MAbs identified

June 7, 1996

Hoescht reports imidobisphosphonic acid derivatives

June 7, 1996

Fujisawa claims ACAT inhibitors

June 7, 1996

Indena claims colchicine derivatives

June 7, 1996

E. Merck describes immunoconjugates

June 7, 1996

Knoll describes antiarthritic and immunomodulator derivatives

June 7, 1996

Toyama reveals antiherpes compounds

June 7, 1996

Kyowoa Hakko's RP-1551-2: a novel antimicrobial agent

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...